Velo3D Announces Third Quarter 2021 Financial Results
Velo3D, Inc. (NYSE: VLD) reported strong third quarter 2021 results with revenue of $8.7 million, a 22% increase from Q2, driven by higher Sapphire® system sales. Shipments rose 50% year-to-date, totaling 15 systems, while gross margin decreased to 17% due to increased overhead costs. The merger with JAWS Spitfire generated $274 million in net cash, bolstering liquidity for future growth. The company forecasts $89 million in revenue for 2022, supported by a significant backlog and customer demand.
- Revenue increased by 22% from Q2 2021, reaching $8.7 million.
- Shipments rose by 50% year-to-date, from 10 in 2020 to 15 in 2021.
- Strong demand for Sapphire® XC solution, with $40 million in bookings and $45 million in pre-orders as of October.
- Merger with JAWS Spitfire generated approximately $274 million in net cash proceeds.
- Positive guidance for 2022 revenue forecast at $89 million, supported by a significant backlog.
- Gross margin decreased to 17% from 31% in Q2 due to increased overhead and material costs.
- Net loss of $66.6 million for the quarter, including a $51 million extraordinary charge related to the merger.
- Operating expenses rose 18% sequentially to $16.5 million, driven by expansion-related costs.
- Completed merger transaction to become publicly traded company
-
Strong revenue growth –
23% sequential increase from Q2 -
Shipments up
50% YTD – 15 in 2021 vs 10 in 2020 - Strong third quarter bookings - 10 systems in Q3 vs 6 in Q2
-
Market expansion into
Europe – first system shipped to EU customer - Sapphire® XC development program on track – first customer parts printed in Q3
-
Significant backlog for 2022 – 17 XC firm orders,
total bookings/pre-orders$85M
“Our strong third quarter results reflect increasing demand for our industry changing end-to-end Sapphire® solution which is redefining the production of high value metal parts for mission critical applications”, said
“One of the key highlights for the quarter was the closing of our merger with JAWS Spitfire. This merger was a huge milestone for the Company, enabling us to become a publicly traded company and generating approximately
“Operationally, we were also pleased with our strong growth momentum as we exceeded our revenue target and posted very strong bookings for the quarter. Demand for our new Sapphire® XC system continues to grow strongly with bookings of
“Given our industry leading technology, increasing demand from our diverse customer base, strong balance sheet and a focus on maintaining our commitment to quality, we believe we are well positioned for future growth as we continue to push the boundaries of what is achievable with metal additive manufacturing”, concluded Buller.
($ Millions, except percentages and per-share data) |
3rd Quarter
|
2nd Quarter
|
3rd Quarter
|
GAAP revenue |
|
|
|
GAAP gross margin |
|
|
|
GAAP net income (loss)1 |
( |
( |
( |
GAAP net income (loss) per diluted share |
( |
( |
( |
|
|
|
|
Non-GAAP net income (loss)2 |
( |
( |
( |
Non-GAAP net income (loss) per diluted share2 |
( |
( |
( |
Cash |
|
|
|
Information about Velo3d’s use of non-GAAP information, including a reconciliation to |
|
1. |
Third quarter 2021 results include |
2. |
Reconciliations to |
Summary of Third Quarter results
Revenue for the third quarter was
The Company shipped 5 systems in the third quarter and 15 year to date. Year to date shipments rose
Gross margin for the quarter was
Operating expenses for the quarter rose
Net loss for the quarter was
The Company ended the quarter with a strong balance sheet with
Guidance
For fiscal year 2021, the Company is providing the following guidance.
a. Revenue of
b. Total Sapphire® shipments – 22-24
c. Total Sapphire® bookings – more than 24
d. Total Sapphire® XC backlog - 20
e. New customer additions – 12-15
For fiscal year 2022, given its significant backlog and increasing demand for its Sapphire® XC solution, the Company remains confident in its ability to achieve its 2022 revenue forecast of
The Company will host a conference call for investors this afternoon to discuss its third quarter 2021 performance at
About
Forward-Looking Statements:
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s guidance for full year 2021 (including the Company’s estimates for revenue, total Sapphire® shipments, total Sapphire® bookings, total Sapphire® XC backlog and new customer additions), the Company’s revenue forecast for 2022 and its ability to achieve such forecast, the timing of the Company’s first Sapphire® XC shipment, the timing of the Company’s manufacturing facility expansion, the Company’s ability to meet demand forecasts through 2024, the anticipated financial impacts of the merger transaction with JAWS Spitfire, the expected benefits of the Company’s investments, the Company’s expectations regarding its capital requirements, and the Company’s other expectations, hopes, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the definitive proxy statement/prospectus relating to the business combination (the “Proxy Statement/Prospectus”), which was filed by JAWS Spitfire with the
Non-GAAP Financial Information
The Company uses non-GAAP financial measures to help it make strategic decisions, establish budgets and operational goals for managing its business, analyze its financial results and evaluate its performance. The Company also believes that the presentation of these non-GAAP financial measures in this release provides an additional tool for investors to use in comparing the Company’s core business and results of operations over multiple periods. However, the non-GAAP financial measures presented in this release may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. The non-GAAP financial measures presented in this release should not be considered as the sole measure of the Company’s performance and should not be considered in isolation from, or as a substitute for, comparable financial measures calculated in accordance with generally accepted accounting principles accepted in
The information in the table below sets forth the non-GAAP financial measures that the Company uses in this release. Because of the limitations associated with these non-GAAP financial measures, “EBITDA,” “Adjusted EBITDA”, “Non-GAAP Net Income (loss)”, and “Adjusted Operating Expenses”, should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. The Company compensates for these limitations by relying primarily on its GAAP results and using EBITDA, Adjusted EBITDA, Non-GAAP Net Income (loss) and Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the Company business.
The following table reconciles Net loss to EBITDA, Adjusted EBITDA, Non-GAAP Net Income (loss) and Total Operating Expenses to Adjusted Operating Expenses during the three and nine months ended
NON-GAAP Net Income (Loss) Reconciliation (Unaudited) |
||||||||||||||||||||||||||||||||||||||||||
|
|
Three months ended
|
|
Nine months ended
|
|
Three months ended
|
||||||||||||||||||||||||||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||||||||||||||||||||
|
|
(In thousands, except for percentages) |
||||||||||||||||||||||||||||||||||||||||
|
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
||||||||||||||||||||||||
Revenues |
|
$ |
8,711 |
|
|
100.0 |
% |
|
$ |
2,273 |
|
|
100.0 |
% |
|
$ |
17,029 |
|
|
100.0 |
% |
|
$ |
12,233 |
|
|
100.0 |
% |
|
$ |
7,146 |
|
|
100.0 |
% |
|
$ |
3,561 |
|
|
100.0 |
% |
Gross profit |
|
1,474 |
|
|
16.9 |
% |
|
488 |
|
|
21.5 |
% |
|
3,268 |
|
|
19.2 |
% |
|
3,993 |
|
|
32.6 |
% |
|
2,184 |
|
|
30.6 |
% |
|
1,589 |
|
|
44.6 |
% |
||||||
Net income (loss) |
|
$ |
(66,578 |
) |
|
(764.3 |
)% |
|
$ |
(7,107 |
) |
|
(312.7 |
)% |
|
$ |
(92,663 |
) |
|
(544.1 |
)% |
|
$ |
(17,591 |
) |
|
(143.8 |
)% |
|
$ |
(12,536 |
) |
|
(175.4 |
)% |
|
$ |
(4,782 |
) |
|
(134.3 |
)% |
Stock based compensation |
|
676 |
|
|
7.8 |
% |
|
466 |
|
|
20.5 |
% |
|
1,751 |
|
|
10.3 |
% |
|
1,243 |
|
|
10.2 |
% |
|
760 |
|
|
10.6 |
% |
|
389 |
|
|
10.9 |
% |
||||||
Loss on fair value on the convertible note modification |
|
50,577 |
|
|
580.6 |
% |
|
— |
|
|
— |
% |
|
50,577 |
|
|
297.0 |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
||||||
Loss/(gain) on fair value of warrants |
|
1,892 |
|
|
21.7 |
% |
|
2 |
|
|
0.1 |
% |
|
3,633 |
|
|
21.3 |
% |
|
(5 |
) |
|
— |
% |
|
227 |
|
|
3.2 |
% |
|
(3 |
) |
|
(0.1 |
)% |
||||||
Gain on fair value of contingent earnout liabilities |
|
(2,014 |
) |
|
(23.1 |
)% |
|
— |
|
|
— |
% |
|
(2,014 |
) |
|
(11.8 |
)% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
||||||
Merger related transactional costs |
|
846 |
|
|
9.7 |
% |
|
— |
|
|
— |
% |
|
4,360 |
|
|
25.6 |
% |
|
— |
|
|
— |
% |
|
1,583 |
|
|
22.2 |
% |
|
— |
|
|
— |
% |
||||||
Non-GAAP Net income (loss) |
|
$ |
(14,601 |
) |
|
(167.6 |
)% |
|
$ |
(6,639 |
) |
|
(292.1 |
)% |
|
$ |
(34,356 |
) |
|
(201.7 |
)% |
|
$ |
(16,353 |
) |
|
(133.7 |
)% |
|
$ |
(9,966 |
) |
|
(139.5 |
)% |
|
$ |
(4,396 |
) |
|
(123.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted |
|
$ |
(0.74 |
) |
|
|
|
$ |
(0.42 |
) |
|
|
|
$ |
(1.98 |
) |
|
|
|
$ |
(1.05 |
) |
|
|
|
$ |
(0.62 |
) |
|
|
|
$ |
(0.28 |
) |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Weighted-average shares used in computing non-GAAP net loss per share attributable to common stockholders, basic and diluted |
|
19,793,868 |
|
|
|
|
15,994,154 |
|
|
|
|
17,348,557 |
|
|
|
|
15,503,475 |
|
|
|
|
16,150,202 |
|
|
|
|
15,774,755 |
|
|
|
||||||||||||
NON-GAAP Adjusted EBITDA Reconciliation (Unaudited) |
|||||||||||||||||||||||||||||||||||||||||
|
Three months ended |
|
Nine months ended |
|
Three months ended |
||||||||||||||||||||||||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||||||||||||||||||||
|
(In thousands, except for percentages) |
||||||||||||||||||||||||||||||||||||||||
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
||||||||||||||||||||||||
Revenues |
$ |
8,711 |
|
|
100.0 |
% |
|
$ |
2,273 |
|
|
100.0 |
% |
|
$ |
17,029 |
|
|
100.0 |
% |
|
$ |
12,233 |
|
|
100.0 |
% |
|
$ |
7,146 |
|
|
100.0 |
% |
|
$ |
3,561 |
|
|
100.0 |
% |
Net loss |
(66,578 |
) |
|
(764.3 |
)% |
|
(7,107 |
) |
|
(312.7 |
)% |
|
(92,663 |
) |
|
(544.1 |
)% |
|
(17,591 |
) |
|
(143.8 |
)% |
|
(12,536 |
) |
|
(175.4 |
)% |
|
(4,782 |
) |
|
(134.3 |
)% |
||||||
Interest expense |
986 |
|
|
11.3 |
% |
|
48 |
|
|
2.1 |
% |
|
1,630 |
|
|
9.6 |
% |
|
200 |
|
|
1.6 |
% |
|
524 |
|
|
7.3 |
% |
|
71 |
|
|
2.0 |
% |
||||||
Tax expense |
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
||||||
Depreciation and amortization |
584 |
|
|
6.7 |
% |
|
322 |
|
|
14.2 |
% |
|
1,276 |
|
|
7.5 |
% |
|
851 |
|
|
7.0 |
% |
|
221 |
|
|
3.1 |
% |
|
273 |
|
|
7.7 |
% |
||||||
EBITDA |
$ |
(65,008 |
) |
|
(746.3 |
)% |
|
$ |
(6,737 |
) |
|
(296.4 |
)% |
|
$ |
(89,757 |
) |
|
(527.1 |
)% |
|
$ |
(16,540 |
) |
|
(135.2 |
)% |
|
$ |
(11,791 |
) |
|
(165.0 |
)% |
|
$ |
(4,438 |
) |
|
(124.6 |
)% |
Stock based compensation |
676 |
|
|
7.8 |
% |
|
466 |
|
|
20.5 |
% |
|
1,751 |
|
|
10.3 |
% |
|
1,243 |
|
|
10.2 |
% |
|
760 |
|
|
10.6 |
% |
|
389 |
|
|
10.9 |
% |
||||||
Loss/(gain) on fair value of warrants |
1,892 |
|
|
21.7 |
% |
|
2 |
|
|
0.1 |
% |
|
3,633 |
|
|
21.3 |
% |
|
(5 |
) |
|
— |
% |
|
227 |
|
|
3.2 |
% |
|
(3 |
) |
|
(0.1 |
)% |
||||||
Gain on fair value of contingent earnout liabilities |
(2,014 |
) |
|
(23.1 |
)% |
|
— |
|
|
— |
% |
|
(2,014 |
) |
|
(11.8 |
)% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
||||||
Adjusted EBITDA |
$ |
(64,454 |
) |
|
(739.9 |
)% |
|
$ |
(6,269 |
) |
|
(275.8 |
)% |
|
$ |
(86,387 |
) |
|
(507.3 |
)% |
|
$ |
(15,302 |
) |
|
(125.1 |
)% |
|
$ |
(10,804 |
) |
|
(151.2 |
)% |
|
$ |
(4,052 |
) |
|
(113.8 |
)% |
Merger related transactional costs |
846 |
|
|
9.7 |
% |
|
— |
|
|
— |
% |
|
4,360 |
|
|
25.6 |
% |
|
— |
|
|
— |
% |
|
1,583 |
|
|
22.2 |
% |
|
— |
|
|
— |
% |
||||||
Loss on fair value on the convertible note modification |
50,577 |
|
|
580.6 |
% |
|
— |
|
|
— |
% |
|
50,577 |
|
|
297.0 |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
||||||
Adjusted EBITDA excluding merger related transactional costs and loss on fair value on the convertible note modification |
$ |
(13,031 |
) |
|
(149.6 |
)% |
|
$ |
(6,269 |
) |
|
(275.8 |
)% |
|
$ |
(31,450 |
) |
|
(184.7 |
)% |
|
$ |
(15,302 |
) |
|
(125.1 |
)% |
|
$ |
(9,221 |
) |
|
(129.0 |
)% |
|
$ |
(4,052 |
) |
|
(113.8 |
)% |
NON-GAAP Adjusted Operating Expenses Reconciliation (Unaudited) |
|||||||||||||||||||||||||||||||||||
|
Three months ended |
|
Nine months ended |
|
Three months ended |
||||||||||||||||||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||||||||||||||
|
(In thousands, except for percentages) |
||||||||||||||||||||||||||||||||||
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
||||||||||||||||||
Revenue |
$ |
8,711 |
|
100.0 |
% |
|
$ |
2,273 |
|
100.0 |
% |
|
$ |
17,029 |
|
100.0 |
% |
|
$ |
12,233 |
|
100.0 |
% |
|
$ |
7,146 |
|
100.0 |
% |
|
$ |
3,561 |
|
100.0 |
% |
Cost of revenue |
7,237 |
|
83.1 |
% |
|
1,785 |
|
78.5 |
% |
|
13,761 |
|
80.8 |
% |
|
8,240 |
|
67.4 |
% |
|
4,962 |
|
69.4 |
% |
|
1,972 |
|
55.4 |
% |
||||||
Gross profit |
$ |
1,474 |
|
16.9 |
% |
|
$ |
488 |
|
21.5 |
% |
|
$ |
3,268 |
|
19.2 |
% |
|
$ |
3,993 |
|
32.6 |
% |
|
$ |
2,184 |
|
30.6 |
% |
|
$ |
1,589 |
|
44.6 |
% |
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Research and development |
7,987 |
|
91.7 |
% |
|
4,043 |
|
177.9 |
% |
|
19,081 |
|
112.1 |
% |
|
10,917 |
|
89.2 |
% |
|
6,399 |
|
89.5 |
% |
|
3,165 |
|
88.9 |
% |
||||||
Selling and marketing |
3,346 |
|
38.4 |
% |
|
1,526 |
|
67.1 |
% |
|
7,706 |
|
45.3 |
% |
|
4,401 |
|
36.0 |
% |
|
2,337 |
|
32.7 |
% |
|
1,362 |
|
38.2 |
% |
||||||
General and administrative |
5,158 |
|
59.2 |
% |
|
1,941 |
|
85.4 |
% |
|
15,162 |
|
89.0 |
% |
|
6,069 |
|
49.6 |
% |
|
5,218 |
|
73.0 |
% |
|
1,788 |
|
50.2 |
% |
||||||
Total operating expenses |
$ |
16,491 |
|
189.3 |
% |
|
$ |
7,510 |
|
330.4 |
% |
|
$ |
41,949 |
|
246.3 |
% |
|
$ |
21,387 |
|
174.8 |
% |
|
$ |
13,954 |
|
195.3 |
% |
|
$ |
6,315 |
|
177.3 |
% |
Stock based compensation |
676 |
|
7.8 |
% |
|
466 |
|
20.5 |
% |
|
1,751 |
|
10.3 |
% |
|
1,243 |
|
10.2 |
% |
|
760 |
|
10.6 |
% |
|
389 |
|
10.9 |
% |
||||||
Merger related transactional costs |
846 |
|
9.7 |
% |
|
— |
|
— |
% |
|
4,360 |
|
25.6 |
% |
|
— |
|
— |
% |
|
1,583 |
|
22.2 |
% |
|
— |
|
— |
% |
||||||
Adjusted operating expenses |
$ |
14,969 |
|
171.8 |
% |
|
$ |
7,044 |
|
309.9 |
% |
|
$ |
35,838 |
|
210.5 |
% |
|
$ |
20,144 |
|
164.7 |
% |
|
$ |
11,611 |
|
162.5 |
% |
|
$ |
5,926 |
|
166.4 |
% |
Condensed Statements of Operations and Comprehensive Loss (Unaudited) |
|||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
(in thousands, except share and per share data) |
||||||||||||||
Revenue |
$ |
8,711 |
|
|
$ |
2,273 |
|
|
$ |
17,029 |
|
|
$ |
12,233 |
|
Cost of revenue |
7,237 |
|
|
1,785 |
|
|
13,761 |
|
|
8,240 |
|
||||
Gross profit |
1,474 |
|
|
488 |
|
|
3,268 |
|
|
3,993 |
|
||||
Operating expenses |
|
|
|
|
|
|
|
||||||||
Research and development |
7,987 |
|
|
4,043 |
|
|
19,081 |
|
|
10,917 |
|
||||
Selling and marketing |
3,346 |
|
|
1,526 |
|
|
7,706 |
|
|
4,401 |
|
||||
General and administrative |
5,158 |
|
|
1,941 |
|
|
15,162 |
|
|
6,069 |
|
||||
Total operating expenses |
16,491 |
|
|
7,510 |
|
|
41,949 |
|
|
21,387 |
|
||||
Loss from operations |
(15,017 |
) |
|
(7,022 |
) |
|
(38,681 |
) |
|
(17,394 |
) |
||||
Interest expense |
(986 |
) |
|
(48 |
) |
|
(1,630 |
) |
|
(200 |
) |
||||
Loss on fair value on the convertible note modification |
(50,577 |
) |
|
— |
|
|
(50,577 |
) |
|
— |
|
||||
Loss/(gain) on fair value of warrants |
(1,892 |
) |
|
(2 |
) |
|
(3,633 |
) |
|
5 |
|
||||
Gain on fair value of contingent earnout liabilities |
2,014 |
|
|
— |
|
|
2,014 |
|
|
— |
|
||||
Other income (expense), net |
(120 |
) |
|
(35 |
) |
|
(156 |
) |
|
(2 |
) |
||||
Loss before provision for income taxes |
(66,578 |
) |
|
(7,107 |
) |
|
(92,663 |
) |
|
(17,591 |
) |
||||
Provision for income taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
||||
Net loss and comprehensive loss |
$ |
(66,578 |
) |
|
$ |
(7,107 |
) |
|
$ |
(92,663 |
) |
|
$ |
(17,591 |
) |
Net loss per share attributable to common stockholders, basic and diluted |
$ |
(3.36 |
) |
|
$ |
(0.44 |
) |
|
$ |
(5.34 |
) |
|
$ |
(1.13 |
) |
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
19,793,863 |
|
|
15,994,154 |
|
|
17,348,557 |
|
|
15,503,475 |
|
Condensed Balance Sheets (Unaudited) |
|||||||
|
|
|
|
||||
|
2021 |
|
2020 |
||||
|
(in thousands, except share and per share data) |
||||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
296,826 |
|
|
$ |
15,517 |
|
Accounts receivable, net |
6,558 |
|
|
1,232 |
|
||
Inventories |
15,220 |
|
|
7,309 |
|
||
Contract assets |
1,510 |
|
|
3,033 |
|
||
Prepaid expenses and other current assets |
9,069 |
|
|
807 |
|
||
Total current assets |
329,183 |
|
|
27,898 |
|
||
Property and equipment, net |
5,001 |
|
|
1,006 |
|
||
Equipment on lease, net |
7,748 |
|
|
2,855 |
|
||
Other assets |
5,858 |
|
|
932 |
|
||
Total assets |
$ |
347,790 |
|
|
$ |
32,691 |
|
Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Equity (Deficit) |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
33,343 |
|
|
$ |
1,226 |
|
Accrued expenses and other current liabilities |
6,552 |
|
|
2,512 |
|
||
Debt – current portion |
13,731 |
|
|
3,687 |
|
||
Contract liabilities |
17,116 |
|
|
4,702 |
|
||
Total current liabilities |
70,742 |
|
|
12,127 |
|
||
Long-term debt – less current portion |
14,322 |
|
|
4,316 |
|
||
Convertible notes payable |
— |
|
|
— |
|
||
Other noncurrent liabilities |
116,342 |
|
|
365 |
|
||
Total liabilities |
201,406 |
|
|
16,808 |
|
||
Commitments and contingencies (Note 16) |
|
|
|
||||
Redeemable convertible preferred stock, |
— |
|
|
123,704 |
|
||
Stockholders’ equity (deficit): |
|
|
|
||||
Common stock, |
2 |
|
|
1 |
|
||
Additional paid-in capital |
361,821 |
|
|
14,954 |
|
||
Accumulated deficit |
(215,439 |
) |
|
(122,776 |
) |
||
Total stockholders’ equity (deficit) |
146,384 |
|
|
(107,821 |
) |
||
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) |
$ |
347,790 |
|
|
$ |
32,691 |
|
Condensed Statements of Cash Flows (Unaudited) |
||||||||
|
|
Nine months ended |
||||||
|
|
2021 |
|
2020 |
||||
|
|
(In thousands) |
||||||
Cash flows from operating activities |
|
|
|
|
||||
Net loss |
|
$ |
(92,663 |
) |
|
$ |
(17,591 |
) |
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|
||||
Depreciation |
|
1,276 |
|
|
851 |
|
||
Stock-based compensation |
|
1,751 |
|
|
1,243 |
|
||
Loss on fair value on the convertible note modification |
|
50,577 |
|
|
— |
|
||
Loss/(gain) on fair value of warrants |
|
3,633 |
|
|
(5 |
) |
||
Gain on fair value of contingent earnout liabilities |
|
(2,014 |
) |
|
— |
|
||
Changes in assets and liabilities |
|
|
|
|
||||
Accounts receivable |
|
(5,326 |
) |
|
(790 |
) |
||
Inventories |
|
(6,391 |
) |
|
(1,383 |
) |
||
Contract assets |
|
1,523 |
|
|
(133 |
) |
||
Prepaid expenses and other assets |
|
(10,669 |
) |
|
491 |
|
||
Accounts payable |
|
10,019 |
|
|
(624 |
) |
||
Accrued expenses and other liabilities |
|
4,040 |
|
|
(1,239 |
) |
||
Contract liabilities |
|
12,414 |
|
|
(669 |
) |
||
Other noncurrent liabilities |
|
565 |
|
(46 |
) |
|||
Net cash used in operating activities |
|
(31,265 |
) |
|
(19,895 |
) |
||
Cash flows from investing activities |
|
|
|
|
||||
Purchase of property and equipment |
|
(1,534 |
) |
|
(225 |
) |
||
Production of equipment for lease to customers |
|
(6,919 |
) |
|
(2,954 |
) |
||
Net cash used in investing activities |
|
(8,453 |
) |
|
(3,179 |
) |
||
Cash flows from financing activities |
|
|
|
|
||||
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs |
|
— |
|
|
28,278 |
|
||
Proceeds from Merger |
|
317,849 |
|
|
— |
|
||
Payment of transactional cost related to Merger |
|
(19,666 |
) |
|
|
|||
Proceeds from loan refinance |
|
19,339 |
|
|
— |
|
||
Repayment of term loan and equipment loan |
|
(4,819 |
) |
|
— |
|
||
Proceeds from term loan revolver facility |
|
3,000 |
|
|
— |
|
||
Proceeds from equipment loans |
|
5,600 |
|
|
1,550 |
|
||
Repayment of equipment loans |
|
(3,070 |
) |
|
(370 |
) |
||
Proceeds from convertible notes |
|
5,000 |
|
|
5,415 |
|
||
Issuance of common stock upon exercise of stock options |
|
313 |
|
|
53 |
|
||
Net cash provided by financing activities |
|
323,546 |
|
|
34,926 |
|
||
Net change in cash and cash equivalents |
|
283,828 |
|
|
11,852 |
|
||
Cash and cash equivalents at beginning of period |
|
15,517 |
|
|
9,815 |
|
||
Cash and cash equivalents at end of period |
|
$ |
299,345 |
|
|
$ |
21,667 |
|
Supplemental disclosure of cash flow information |
|
|
|
|
||||
Cash paid for interest |
|
$ |
857 |
|
|
$ |
187 |
|
Supplemental disclosure of non-cash information |
|
|
|
|
||||
Extinguishment of redeemable convertible preferred stock |
|
$ |
— |
|
|
$ |
13,274 |
|
Conversion of warrants into redeemable convertible preferred stock, net settlement |
|
1,046 |
|
|
— |
|
||
Conversion of convertible notes to Series D redeemable convertible preferred stock |
|
5,000 |
|
|
1,512 |
|
||
Conversion of redeemable convertible preferred stock into common stock |
|
123,704 |
|
|
— |
|
||
Conversion of warrants into common stock, net settlement |
|
3,488 |
|
|
— |
|
||
Reclassification of warrants liability upon the reverse merger |
|
96,547 |
|
|
— |
|
||
Reclassification of contingent earnout liability upon the reverse merger |
|
21,051 |
|
|
— |
|
||
Issuance of common stock warrants in connection with financing |
|
316 |
|
|
— |
|
||
Unpaid liabilities related to property and equipment |
|
3,231 |
|
|
103 |
|
||
Unpaid merger related transactional costs |
|
19,913 |
|
|
— |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006497/en/
Investor Relations:
Bob Okunski, VP Investor Relations
investors@velo3d.com
Media Contact:
dan.sorensen@velo3d.com
Source:
FAQ
What were Velo3D's revenue results for the third quarter of 2021?
How many systems did Velo3D ship in 2021?
What is Velo3D's revenue forecast for 2022?
What impact did the merger have on Velo3D's financial position?